![A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers | Nature Communications A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fncomms12222/MediaObjects/41467_2016_Article_BFncomms12222_Fig1_HTML.jpg)
A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers | Nature Communications
![Targeting HER2 in Breast Cancer: Latest Developments on Treatment Sequencing and the Introduction of Biosimilars | SpringerLink Targeting HER2 in Breast Cancer: Latest Developments on Treatment Sequencing and the Introduction of Biosimilars | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40265-020-01411-y/MediaObjects/40265_2020_1411_Fig1_HTML.png)
Targeting HER2 in Breast Cancer: Latest Developments on Treatment Sequencing and the Introduction of Biosimilars | SpringerLink
![Her2/ERBB2 Protein Overview: Sequence, Structure, Function and Protein Interaction | Sino Biological Her2/ERBB2 Protein Overview: Sequence, Structure, Function and Protein Interaction | Sino Biological](https://cdn1.sinobiological.com/styles/default/images/protein-structure/ERBB2-protein-structure.jpg)
Her2/ERBB2 Protein Overview: Sequence, Structure, Function and Protein Interaction | Sino Biological
Prevalence and Clinicopathological Characteristics of HER2 and BRAF Mutation in Chinese Patients with Lung Adenocarcinoma | PLOS ONE
![Sequence comparison of domain II of EGFR and HER2. Residues that are... | Download Scientific Diagram Sequence comparison of domain II of EGFR and HER2. Residues that are... | Download Scientific Diagram](https://www.researchgate.net/publication/47334992/figure/fig8/AS:601696967352321@1520467144030/Sequence-comparison-of-domain-II-of-EGFR-and-HER2-Residues-that-are-conserved-in-domain.png)
Sequence comparison of domain II of EGFR and HER2. Residues that are... | Download Scientific Diagram
![Development of a molecule-recognized promoter DNA sequence for inhibition of HER2 expression | The Journal of Antibiotics Development of a molecule-recognized promoter DNA sequence for inhibition of HER2 expression | The Journal of Antibiotics](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fja.2009.35/MediaObjects/41429_2009_Article_BFja200935_Fig1_HTML.gif)
Development of a molecule-recognized promoter DNA sequence for inhibition of HER2 expression | The Journal of Antibiotics
![A phase 1 study of a heterologous prime-boost vaccination involving a truncated HER2 sequence in patients with HER2-expressing breast cancer: Molecular Therapy - Methods & Clinical Development A phase 1 study of a heterologous prime-boost vaccination involving a truncated HER2 sequence in patients with HER2-expressing breast cancer: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/2113794906/2084388155/gr1.jpg)